Table 1.
Demographic and clinical data of patients with schizophrenia.
| Mean (SD) n = 23 |
|
|---|---|
| Age (years) | 32.48 (11.24) |
| Age of onset (years) | 20.57 (5.43) |
| Gender (male/female) | 18/5 |
| Duration of illness (years) | 11.91 (9.53) |
| Parental SESa | 7.17 (5.32) |
| RBANS total indexb | 67.96 (11.51) |
| BPRSc Total | 46.52 (11.37) |
| BPRS Positived | 12.52 (4.21) |
| BPRS Negativee | 7.30 (2.65) |
| Antipsychotic medication naïve | 8/23 (34.8%) |
| Time since previous antipsychotic (months)f | 19.39 (38.62) |
| Previous atypical treatmentsg, h | 1.13 (1.39) |
| Previous typical treatmentsg,i | 0.48 (0.79) |
Parental socioeconomic status ranks determined from Diagnostic Interview for Genetic Studies, DIGS (1–18 scale); higher rank (lower numerical value) corresponds to higher socioeconomic status.
Repeatable Battery for the Assessment of Neuropsychological Status
Brief Psychiatric Rating Scale scores recorded at the baseline
Positive scale consisted of conceptual disorganization, hallucinations, unusual thought content, and suspiciousness.
Negative scale consisted of emotional withdrawal, motor retardation, and blunted affect.
Total amount of time since patient last took an antipsychotic medication, which was determined from the patients medical history.
Total number of times that the patient was previously treated with either typical or atypical antipsychotic medication.
Range of previous atypical treatments was 0 – 5 previous treatments.
Range of previous typical treatments was 0 – 3 previous treatments.